FR2858934B1 - Composition pharmaceutique et son application dans le domaine de la neurologie en tant qu'agent modulateur du systeme glutamatergique - Google Patents

Composition pharmaceutique et son application dans le domaine de la neurologie en tant qu'agent modulateur du systeme glutamatergique

Info

Publication number
FR2858934B1
FR2858934B1 FR0310133A FR0310133A FR2858934B1 FR 2858934 B1 FR2858934 B1 FR 2858934B1 FR 0310133 A FR0310133 A FR 0310133A FR 0310133 A FR0310133 A FR 0310133A FR 2858934 B1 FR2858934 B1 FR 2858934B1
Authority
FR
France
Prior art keywords
neurology
application
pharmaceutical composition
field
modulating agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0310133A
Other languages
English (en)
Other versions
FR2858934A1 (fr
Inventor
Jacques Vignon
Helene Hirbec
Alain Privat
Manuel Gaviria
Jean Marc Kamenka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0310133A priority Critical patent/FR2858934B1/fr
Publication of FR2858934A1 publication Critical patent/FR2858934A1/fr
Application granted granted Critical
Publication of FR2858934B1 publication Critical patent/FR2858934B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0310133A 2003-08-22 2003-08-22 Composition pharmaceutique et son application dans le domaine de la neurologie en tant qu'agent modulateur du systeme glutamatergique Expired - Fee Related FR2858934B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0310133A FR2858934B1 (fr) 2003-08-22 2003-08-22 Composition pharmaceutique et son application dans le domaine de la neurologie en tant qu'agent modulateur du systeme glutamatergique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0310133A FR2858934B1 (fr) 2003-08-22 2003-08-22 Composition pharmaceutique et son application dans le domaine de la neurologie en tant qu'agent modulateur du systeme glutamatergique

Publications (2)

Publication Number Publication Date
FR2858934A1 FR2858934A1 (fr) 2005-02-25
FR2858934B1 true FR2858934B1 (fr) 2006-12-29

Family

ID=34112865

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0310133A Expired - Fee Related FR2858934B1 (fr) 2003-08-22 2003-08-22 Composition pharmaceutique et son application dans le domaine de la neurologie en tant qu'agent modulateur du systeme glutamatergique

Country Status (1)

Country Link
FR (1) FR2858934B1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639225B1 (fr) * 1988-11-21 1993-05-21 Centre Nat Rech Scient Compositions pharmaceutiques pour la neuroprotection contenant des arylcyclohexylamines
FR2818147B1 (fr) * 2000-12-20 2005-06-10 Sod Conseils Rech Applic Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine
US20040082543A1 (en) * 2002-10-29 2004-04-29 Pharmacia Corporation Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain

Also Published As

Publication number Publication date
FR2858934A1 (fr) 2005-02-25

Similar Documents

Publication Publication Date Title
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
FR2851470B1 (fr) Composition pharmaceutique pour administration transdermique ou transmuqueuse
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
MA27037A1 (fr) Amides d'acide anthranilique avec une chaine laterale heteroarylsulfonyle, procede pour leur fabrication, leur utilisation comme medicament et comme agent de diagnostic ainsi que les preparations pharmaceutiques en contenant
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
ID26773A (id) Sulfur tersubstitusi pada asam sulfonilaminokarboksilat n-arilamida, persiapan, penggunaan dan persiapan pembuatan obat yang menyertainya
MA26842A1 (fr) Amino-acides bicycliques servant d'agents pharmaceutiques
DK1395242T3 (da) Flydende farmaceutisk sammensætning
AR034371A1 (es) Composiciones farmaceuticas
FR2869228B1 (fr) Utilisation d'un hydrolysat de proteines de cruciferes en tant qu'agent depigmentant dans ou pour une composition cosmetique et/ou pharmaceutique
EE05439B1 (et) Ketotifeeni sisaldav oftalmiline ravimkoostis
DE69838785D1 (de) Pharmazeutische mittel zur behandlung von zerebralen amyloidosis
FR2857263B1 (fr) Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
FR2894142B1 (fr) Utilisation de l'association du dipeptide tyrosine-arginine et de la niacimanide en tant qu'antagoniste de substance p
FR2834896B1 (fr) Composition pharmaceutique orodispersible d'ivabradine
FR2834893B1 (fr) Composition pharmaceutique orodispersible de perindopril
FR2858934B1 (fr) Composition pharmaceutique et son application dans le domaine de la neurologie en tant qu'agent modulateur du systeme glutamatergique
AR026073A1 (es) Composicion farmaceutica acuosa que contiene ciclesonida
DE602004014624D1 (de) Selbst-nanoemulgierende ölige formulierung zur verabreichung von schwer wasserlöslichen arzneimitteln
FR2825279B1 (fr) Medicament utile dans le traitement du cancer
DK1617827T3 (da) Farmaceutisk sammensætning i form af en hydrogel til den transdermale administration af aktivstoffer
FR2804601B1 (fr) Dispositif d'application de principes actifs utilisables dans le domaine pharmaceutique ou cosmetique
ATE413171T1 (de) Pharmazeutische zusammensetzungen mit ascorbinsäure zur behandlung von pilz- superinfektionen und pilz-rezidiven

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20100430